Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Hwang, Jung Ah ^a   Kim, Yujin ^b   Hong, Seung Hyun ^a   Lee, Jieun ^a   Cho, Yong Gu ^a   Han, Ji Youn ^a   Kim, Young Ho ^b   Han, Joungho ^b   Shim, Young Mog ^b   Lee, Yeon Su ^a   Kim, Duk Hwan ^b  

^a National Cancer Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE GLUCOSAMINE 3 O SULFOTRANSFERASE 2; MESSENGER RNA; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DNA METHYLATION ASSAY; ENZYME INACTIVATION; EPIGENETICS; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE SILENCING; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LABORATORY DEVICE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROMOTER REGION;

ADULT; AZACITIDINE; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM INVASIVENESS; PHENOTYPE; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; SULFOTRANSFERASES;

EID: 84896697175     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079634     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96. doi:10.3322/CA.2007.0010. PubMed: 18287387.
2. Kim JS, Kim JW, Han J, Shim YM, Park J et al. (2006) Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Cancer Res 66: 4049-4054. doi:10.1158/0008-5472.CAN-05-3813. PubMed: 16618724.
3. Lindahl U, Kusche-Gullberg M, Kjellén L (1998) Regulated diversity of heparan sulfate. J Biol Chem 273: 24979-24982. doi:10.1074/jbc.273.39.24979. PubMed: 9737951.
4. Hagner-McWhirter A, Li JP, Oscarson S, Lindahl U (2004) Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate. J Biol Chem 279: 14631-14638. doi:10.1074/jbc.M313760200. PubMed: 14718527.
5. Carlsson P, Presto J, Spillmann D, Lindahl U, Kjellén L (2008) Heparin/heparan sulfate biosynthesis. J Biol Chem 283: 20008-20014. doi: 10.1074/jbc.M801652200. PubMed: 18487608.
6. Shworak NW, Liu J, Petros LM, Zhang L, Kobayashi M et al. (1999) Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci. J Biol Chem 274: 5170-5184. doi:10.1074/jbc.274.8.5170. PubMed: 9988767.
7. Esko JD, Lindahl U (2001) Molecular diversity of heparan sulfate. J Clin Invest 108: 169-173. doi:10.1172/JCI13530. PubMed: 11457867.
8. Miyamoto K, Asada K, Fukutomi T, Okochi E, Yagi Y et al. (2003) Methylation-associaterd silencing of heparan D-glucosaminyl 3-O- sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene 22: 274-280. doi:10.1038/sj.onc.1206146. PubMed: 12527896.
9. Dietrich D, Lesche R, Tetzner R, Krispin M, Dietrich J et al. (2009) Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissue. J Histochem Cytochem 57: 477-489. doi:10.1369/jhc.2009.953026. PubMed: 19153192.
10. Gonzalo V, Lozano JJ, Muñoz J, Balaguer F, Pellisé M et al. (2010) Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. PLOS ONE 5: e8777. doi:10.1371/journal.pone.0008777. PubMed: 20098741.
11. Tokuyama Y, Takahashi T, Okumura N, Nonaka K, Kawaguchi Y et al. (2010) Aberrant methylation of heparan sulfate glucosamine 3-O-sulfotransferase 2 genes as a biomarker in colorectal cancer. Anticancer Res 30: 4811-4818. PubMed: 21187457.
12. Bernal C, Aguayo F, Villarroel C, Vargas M, Díaz I et al. (2008) Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res 14: 6264-6269. doi: 10.1158/1078-0432.CCR-07-4522. PubMed: 18829507.
13. Martin-Subero JI, Ammerpohl O, Bibikova M, Wickham-Garcia E, Agirre X et al. (2009) A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLOS ONE 4: e6986. doi: 10.1371/journal.pone.0006986. PubMed: 19750229.
14. Mahapatra S, Klee EW, Young CY, Sun Z, Jimenez RE et al. (2012) Global methylation profiling for risk prediction of prostate cancer. Clin Cancer Res 18: 2882-2895. doi:10.1158/1078-0432.CCR-11-2090. PubMed: 22589488.
15. Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS et al. (2007) Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol 107: 549-553. doi:10.1016/j.ygyno.2007.08.057. PubMed: 17894941.
16. Lim EH, Ng SL, Li JL, Chang AR, Ng J et al. (2010) Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecol Oncol 119: 225-231. doi:10.1016/j.ygyno.2010.07.028. PubMed: 20708786.
17. Edge SB, Byrd DR, Compton CC, Fritz AF, Greene FL et al. (2010) American Joint Committee on Cancer. In: AJCC Cancer Staging Manual, (7th edn). New York: Springer Verlag. pp. 253-270.
18. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E et al. (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33: 6823-6836. doi:10.1093/nar/gki987. PubMed: 16326863.
19. Kim JS, Han J, Shim YM, Park J, Kim DH (2005) Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma. Cancer 104: 1825-1833. doi: 10.1002/cncr.21409. PubMed: 16177988.
20. Ostrovsky O, Berman B, Gallagher J, Mulloy B, Fernig DG et al. (2002) Differential effects of heparin sacharrides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J Biol Chem 277: 2444-2453. doi:10.1074/jbc.M108540200. PubMed: 11714710.
21. Robinson CJ, Stringer SE (2001) The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114: 853-865. PubMed: 11181169.
22. Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT (1994) Interaction of hepatocyte growth factor with heparin sulfate. Elucidation of the major heparin sulfate structural determinants. J Biol Chem 269: 11216-11223. PubMed: 8157651.
23. Pellegrini L (2001) Role of heparin sulfate in fibroblast growth factor signaling a structural view. Curr Opin Struct Biol 11: 629-634. doi: 10.1016/S0959-440X(00)00258-X. PubMed: 11785766.
24. Fatemi M, Hermann A, Gowher H, Jeltsch A (2001) Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur J Biochem 269: 4981-4984. PubMed: 12383256.
25. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW et al. (2001) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416: 552-556. PubMed: 11932749.
26. Belinsky SA, Nikula KJ, Baylin SB, Issa JP (1996) Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci U S A 93: 4045-4050. doi:10.1073/pnas.93.9.4045. PubMed: 8633014.
27. Swafford DS, Middleton SK, Palmisano WA, Nikula KJ, Tesfaigzi J et al. (1997) Frequent aberrant methylation of p16INK4A in primary rat lung tumors. Mol Cell Biol 17: 1366-1374. PubMed: 9032263.
28. Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC et al. (2001) p16INK4a and histologyspecific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 61: 3419-3424. PubMed: 11309302.
29. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK et al. (2001) Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 62: 2370-2377. PubMed: 11956099.